4//SEC Filing
MAP Pharmaceuticals, Inc. 4
Accession 0000950142-10-000389
CIK 0001401923operating
Filed
Mar 7, 7:00 PM ET
Accepted
Mar 8, 8:48 PM ET
Size
10.1 KB
Accession
0000950142-10-000389
Insider Transaction Report
Form 4
PERSEUS SOROS PARTNERS LLC
10% Owner
Transactions
- Sale
Common Stock
2010-03-04$14.15/sh−677$9,580→ 2,830,785 total(indirect: See Footnotes) - Sale
Common Stock
2010-03-05$13.95/sh−4,616$64,393→ 2,826,169 total(indirect: See Footnotes)
Footnotes (5)
- [F1]The price shown in Column 4 is a weighted average sale price. The price range for the sales is $14.00 to $14.23. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- [F2]The securities reported herein are held for the account of Perseus-Soros BioPharmaceutical Fund, LP ("Perseus-Soros") and Perseus-Soros Partners, LLC ("Perseus-Soros Partners"). Perseus-Soros Partners is the general partner of Perseus-Soros.
- [F3]Represents 677 shares of the Issuer's Common Stock sold by Perseus-Soros Partners. After the sale Perseus-Soros Partners owns directly 4,616 shares of the Issuer's Common Stock.
- [F4]The price shown in Column 4 is a weighted average sale price. The price range for the sales is $13.70 to $14.39. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- [F5]Represents 4,616 shares of the Issuer's Common Stock sold by Perseus-Soros Partners. After the sale Perseus-Soros Partners directly owns no shares of the Issuer's Common Stock.
Issuer
MAP Pharmaceuticals, Inc.
CIK 0001401923
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001401923
Filing Metadata
- Form type
- 4
- Filed
- Mar 7, 7:00 PM ET
- Accepted
- Mar 8, 8:48 PM ET
- Size
- 10.1 KB